Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Everolimus on CKD Progression in ADPKD Patients

This study has been terminated.
(After primary completition date, experimental drug was no longer available)
Sponsor:
Information provided by (Responsible Party):
Prof. Francesco Locatelli, A. Manzoni Hospital
ClinicalTrials.gov Identifier:
NCT01009957
First received: November 6, 2009
Last updated: June 22, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2015
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)